Rockwell Medical (RMTI) Retained Earnings (2010 - 2026)
Rockwell Medical (RMTI) reported Retained Earnings of -$404.6 million for Q1 2026, down 674428.33% on a YoY basis from N/an in Q1 2025, and little changed quarter-over-quarter from -$403.0 million in Q4 2025.
Rockwell Medical (RMTI) Retained Earnings (2010 - 2026) Analysis & Trends
Rockwell Medical has reported Retained Earnings for 17 years, with the latest figure at -$404.6 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 674428.33% year-over-year to -$404.6 million; the trailing twelve-month figure through Mar 2026 stood at -$404.6 million (down 674428.33% YoY), and the FY2025 full-year result was -$403.0 million, down 1.34% from the prior year.
- Retained Earnings for Q1 2026 stood at -$404.6 million, roughly flat from -$403.0 million in the prior quarter.
- The five-year high for Retained Earnings was $163000.0 in Q4 2022, with the low at -$404.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$139.7 million across 5 years, with a median of $8000.0 in 2024.
- Annual changes were most pronounced in 2024 — Retained Earnings slumped 39767700.0% — and 2025, when it surged 1240.0%.
- Rockwell Medical's Retained Earnings stood at $163000.0 in 2022, then sank by 100.61% to -$1000.0 in 2023, then tumbled by 39767700.0% to -$397.7 million in 2024, then fell by 1.34% to -$403.0 million in 2025, then dropped by 0.4% to -$404.6 million in 2026.
- The last three Retained Earnings figures came in at -$404.6 million (Q1 2026), -$403.0 million (Q4 2025), and $73000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -1.87 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -4.41 Mn |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | -404.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -404.60 Mn |
| Dec 31, 2025 | -402.99 Mn |
| Sep 30, 2025 | 73,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 60,000.00 |
| Dec 31, 2024 | -397.68 Mn |
| Sep 30, 2024 | 8,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 68,000.00 |
| Jun 30, 2023 | -393.81 Mn |
| Mar 31, 2023 | -390.51 Mn |
| Dec 31, 2022 | 163,000.00 |
| Sep 30, 2022 | -386.40 Mn |
| Jun 30, 2022 | 49,000.00 |
| Mar 31, 2022 | 51,000.00 |
| Dec 31, 2021 | -370.08 Mn |
| Sep 30, 2021 | -361.10 Mn |
| Jun 30, 2021 | -353.56 Mn |